Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study.

Solenne LouisonPierre Henri GabrielleAgnès SoudryCyril MeillonJulie BlancGuillaume BéalSophie ArsèneYannick Le MerJean-Paul BerrodLaurent KodjikianCatherine P Creuzot Garchernull null

Published in: Acta ophthalmologica (2020)

No cases of uncontrolled or severe perioperative haemorrhage in patients continuing antithrombotic agents were reported in this selected population. For the majority of the patients taking antiplatelets or anticoagulants, these agents could be safely continued during macular surgery.

Keyphrases

end stage renal disease
ejection fraction
minimally invasive
newly diagnosed
chronic kidney disease
atrial fibrillation
peritoneal dialysis
prognostic factors
coronary artery bypass
cardiac surgery
diabetic retinopathy
patient reported outcomes
early onset
surgical site infection
patient reported